Key facts
- This page summarizes PERCEPTIVE ADVISORS LLC's Form 3 filing for Immatics N.V. (IMTX).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 16:00.
PERCEPTIVE ADVISORS LLC - 18 Mar 2026 Form 3 Insider Report for Immatics N.V. (IMTX)
- Reporting relationship
- Director
- Issuer ticker
- IMTX
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 Mar 2026, 16:00:12 UTC
- Prior SEC filing
- 11 Mar 2026
- Next SEC filing
- 10 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
PERCEPTIVE ADVISORS LLC filed Form 3 for Immatics N.V. (IMTX) on 18 Mar 2026.
Change
- Previous filing in this sequence was filed on 11 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (3)
CIK 0001224962
Primary reporting owner
PERCEPTIVE ADVISORS LLC
- Relationship
- Director
- Address
- 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
- Signature
- /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
- Signature date
- 18 Mar 2026
CIK 0001164426
EDELMAN JOSEPH
- Relationship
- Director
- Address
- 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
- Signature
- /s/ Joseph Edelman - for Perceptive Life Sciences Master Fund, Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member
- Signature date
- 18 Mar 2026
CIK 0001249675
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
- Relationship
- Director
- Address
- 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
- Signature
- /s/ Joseph Edelman
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMTX
holding
Ordinary Shares, nominal value EUR 0.01 per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,383,456
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Footnotes
- F1, F6
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMTX
holding
Derivative
Director Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 25,000
- Exercise price
- $10.00
- Footnotes
- F2, F5, F6
IMTX
holding
Derivative
Director Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 15,000
- Exercise price
- $11.00
- Footnotes
- F3, F5, F6
IMTX
holding
Derivative
Director Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 25,000
- Exercise price
- $7.94
- Footnotes
- F5, F6
IMTX
holding
Derivative
Director Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 25,000
- Exercise price
- $11.41
- Footnotes
- F5, F6
IMTX
holding
Derivative
Director Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 40,000
- Exercise price
- $12.00
- Footnotes
- F5, F6
IMTX
holding
Derivative
Director Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 41,500
- Exercise price
- $5.44
- Footnotes
- F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to the Master Fund. Joseph Edelman is the managing member of the Advisor.
Footnote F2
This option was granted on June 30, 2020 and is fully vested.
Footnote F3
This option was granted on December 9, 2021 and is fully vested.
Footnote F4
This option was granted on June 24, 2025 and will vest in full on the first anniversary of the grant date.
Footnote F5
Consists of options to purchase the Issuer's ordinary shares awarded to Adam Stone in connection with his role as a member of the Issuer's board of directors. Mr. Stone is the Chief Investment Officer of the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Master Fund has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset.
Footnote F6
The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.